Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 22 min ago
Peer-reviewedLicence not statedPsychedelic Medicine

Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder

  • Alexander Bystritsky1
  • Andrew A.E.D. Bishay1,2
  • Norman M. Spivak1,3,4
  • Rod Paulsen1
  • Michael Treanor1,5
  • Michael S. Fanselow1,5
  • Michelle G. Craske1,5
5 affiliations
  1. 1Department of Psychiatry & Biobehavioral Sciences, UCLA, Los Angeles, California, USA.
  2. 2Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  3. 3Department of Neurosurgery, UCLA, Los Angeles, California, USA.
  4. 4UCLA-Caltech Medical Scientist Training Program, Los Angeles, California, USA.
  5. 5Department of Psychology, Staglin Center for Brain and Behavioral Health, UCLA, Los Angeles, California, USA.
Read full textDOICite

Related

  1. Positive Allosteric Modulation of mGlu and Muscarinic Receptors Differentially Regulate Nitric Oxide-Dependent Signaling in a Scopolamine-Induced Model of Cognitive Impairment
    Grzegorz Burnat, Michał Santocki, Anna Siekierzycka +3
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Host response against SARS-CoV-2 infection is impacted by allosteric modulation of cholinergic and purinergic receptors
    V. Perraud, G. Dias de Melo, M. Cecchini +5
    bioRxivPreprintCC BYFull textPhysiologybioRxiv
  3. Effects of Endocannabinoid System Modulation on Cholinergic-Induced Anxiety-like Behaviors in Mice.
    Marta Kruk-Slomka, Tomasz Slomka, Agnieszka Dzik +1
    Pharmaceuticals (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Contextual modulation of fear extinction as predictor of exposure therapy effectiveness
    Lotte Stemerding, Mirjam Kampman, Agnes van Minnen +3
    PsyArXivPreprintCC0Full textPsychiatry & mental healthOSF
  5. Reconsidering the Diagnosis and Management of Obinutuzumab-induced Acute Thrombocytopenia
    Shinya Fujita
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedGeneral medicineJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{bystritsky2026letter,
  title = {{Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder}},
  author = {Alexander Bystritsky and Andrew A.E.D. Bishay and Norman M. Spivak and Rod Paulsen and Michael Treanor and Michael S. Fanselow and Michelle G. Craske},
  journal = {Psychedelic Medicine},
  year = {2026},
  month = nov,
  doi = {10.1177/28314425261505125},
  url = {https://doi.org/10.1177/28314425261505125},
}
RIS
TY  - JOUR
TI  - Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder
AU  - Alexander Bystritsky
AU  - Andrew A.E.D. Bishay
AU  - Norman M. Spivak
AU  - Rod Paulsen
AU  - Michael Treanor
AU  - Michael S. Fanselow
AU  - Michelle G. Craske
PY  - 2026
DA  - 2026/11/04
JO  - Psychedelic Medicine
DO  - 10.1177/28314425261505125
UR  - https://doi.org/10.1177/28314425261505125
SN  - 2831-4425
SN  - 2831-4433
ER  -